TopLevel: No

Venator to enter Chapter 11

22nd May 2023

Submitted by:

Andrew Warmington

Venator Materials has announced that it has reached an agreement with “the overwhelming majority of

CordenPharma into oligos

11th May 2023

Submitted by:

Andrew Warmington

CordenPharma is entering synthetic oligonucleotide manufacturing via an investment at its CordenPharma Colorado site. This

DSM-Firmenich merger done

11th May 2023

Submitted by:

Andrew Warmington

DSM and Firmenich have completed their merger and will henceforth operate under the name of

EuroAPI enters cosmetics field

11th May 2023

Submitted by:

Andrew Warmington

EuroAPI has begun an initial, multi-million-Euro, four-year manufacturing agreement with Novéal, part of the L’Oréal

Subscribe to Unsorted